Ireland
--:--IST
Starting soon Not applicable

Management of Non-pharmacologic Delirium With the Use of a Nursing-led E-health Project: a Randonmized Controlled Trial

NCT06809894 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2026-04-01
Last updated
2025-05-29

Condition(s) studied

Delirium TreatmentDelirium Confusional StateDelirium in Old Age

Investigational drug(s) / intervention(s)

Application of an action protocol for the management of delirium through the use of non-pharmacological interventionsTradicional management of delirium

Application of an action protocol for the management of delirium through the use of non-pharmacological interventions: The interventions carried out stand out for being non-pharmacological, this avoiding the use of drugs and polypharmacy in elderly patients, avoiding the appearance of clinical complications derived from the side effects that the use of these substances can lead to in the patient. In addition, it also encourages the education of health professionals and nurses' families or caregivers in the management of delirium.

Tradicional management of delirium: The use of the pharmacological treatment and the mechanical patients restrain were de base of the traditional treatment in deliriums patient in the University hospital of Igualada, because of the less knowledge of the professionals and non-existence protocol of non-pharmacological interventions to management the delirium.

Study summary

Application of an action protocol focused on the application of non-pharmacological interventions for managing delirium in the process of prevention, diagnosis and treatment, evaluated using an e-health intervention, with a tablet to introduce on it the data about the prevention, diagnostic and treatment process of each recluted patient, in the Igualada Hospital Center, once a day.

Eligibility

Sex
ALL
Min age
80 Years
Max age
130 Years
Healthy volunteers
Accepted
Inclusion criteria: * Age over 80 years * Three risk factor to develop delirium, for example: sex (men), polypharmacy,urinary tract infections (UTIs) or strictures. * Admission in geriatric unit. * Have social support Exclusion criteria: * Age under 80 years * Eseeable death on admission not caused by delirium or delirium diagnosis on admission.

Primary outcome measure(s)

  • Rate of patients who develop delirium — Its calculation is carried out during the 3 months of the study, and within each particular case, It is carried out in the morning every day, from admission to discharge of the patient, up to 3 days.
    It is performed on all patients admitted to geriatric unit with 3 or more risk criteria for the development of delirium. Its measurement is carried out in the morning shift using the Confussional Assesment Scale scale. The score is from 0 to 4 points, with a positive diagnosis being one with a score greater than 2. It compares the incidence of the control group and the intervention group.
  • Rate of patients diagnosed with delirium improving clinical severity — Its calculation is carried out during the three months of the study, and within each particular case, in the morning every day, from the beginning of diagnosis to the improvement of the patient, up to 3 days.
    Every patient with a positive diagnostic and an active treatment. The objective is to avaluate the reduction of the symptoms with the Delirium Rating Scale-R-98 scale, in the morning, comparing control gropu and interventional group . The score is from 0 to 48 points, with a positive diagnosis with severity symptoms in scores greater than 12 points.
  • Drug use rate for the treatment of delirium — Its calculation is carried out during the 3 months of the study, and within each particular case, in the end of the patient hospitalitzation, up to 3 days.
    Carried out with the recorded on the e-health program and the observation of the clinical history of each patient who have had a positive diagnosis of delirium in their hospitalitzation in the geriatric unit and has recorded the use of drugs, like number of a day and type of drug, for their treatment. Comparation control group and intervention group.

Trial sites (1)

FacilityCityRegionStatus
Hospital d'Igualada Igualada Barcelona
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06809894 on ClinicalTrials.gov ↗ ← All trials in Spain